Literature DB >> 25946231

Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.

Yukiko Shishido-Hara1,2.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease caused by reactivation of the asymptomatic persistent pathogen human polyomavirus JC (JC virus). The pathology of affected brain tissues demonstrates oligodendroglia-like cells with viral inclusions in their enlarged nuclei, a diagnostic hallmark of this disease. Today, the pathological features of this disease are expanding, partly due to an unsteady balance between viral virulence and host immunity. Intranuclear viral inclusions were initially thought to be amphophilic materials comprising the entire enlarged nucleus, based on HE staining (full inclusions). Howevewr, recent immunohistochemical analyses detected the presence of intranuclear viral inclusions in dots (dot-shaped inclusions). The dot-shaped inclusions reflect clustered progeny virions at punctuated subnuclear domains called promyelocytic leukemia nuclear bodies, and are indicative of early-stage viral infection or suppressed viral proliferation. Second, the JC virus is usually reactivated in patients with impaired immunity, and therefore the inflammatory reactions are poor. However, the causes of immunosuppression are divergent, as seen with the frequent use of immunosuppressive drugs, including natalizumab. Therefore, the degree of host immunity is variable; some patients show marked anti-viral inflammatory reactions and a good prognosis, indicating that a strong resistance against viral infection remains. Recovery of the immune system may also induce paradoxical clinical worsening, known as immune reconstitution inflammatory syndrome, the mechanism of which has not been clarified. The virus-host interactions have increased in complexity, and the pathology of PML is diverging. In this review, the pathology of PML will be described, with a focus on the intranuclear target of JC virus infection and host inflammatory reactions.
© 2015 Japanese Society of Neuropathology.

Entities:  

Keywords:  IRIS; JC virus; PML; natalizumab; progressive multifocal leukoencephalopathy

Mesh:

Year:  2015        PMID: 25946231     DOI: 10.1111/neup.12203

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  6 in total

Review 1.  Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.

Authors:  Joshua Kuruvilla; Andrew Octavian Sasmita; Anna Pick Kiong Ling
Journal:  Neurol Sci       Date:  2018-08-03       Impact factor: 3.307

Review 2.  Emerging From the Unknown: Structural and Functional Features of Agnoprotein of Polyomaviruses.

Authors:  A Sami Saribas; Pascale Coric; Anahit Hamazaspyan; William Davis; Rachel Axman; Martyn K White; Magid Abou-Gharbia; Wayne Childers; Jon H Condra; Serge Bouaziz; Mahmut Safak
Journal:  J Cell Physiol       Date:  2016-02-24       Impact factor: 6.384

3.  Progressive ataxia of Charolais cattle highlights a role of KIF1C in sustainable myelination.

Authors:  Amandine Duchesne; Anne Vaiman; Magali Frah; Sandrine Floriot; Sabrina Legoueix-Rodriguez; Anne Desmazières; Sébastien Fritz; Christian Beauvallet; Olivier Albaric; Eric Venot; Maud Bertaud; Romain Saintilan; Raphaël Guatteo; Diane Esquerré; Julien Branchu; Anaïs Fleming; Alexis Brice; Frédéric Darios; Jean-Luc Vilotte; Giovanni Stevanin; Didier Boichard; Khalid Hamid El Hachimi
Journal:  PLoS Genet       Date:  2018-08-01       Impact factor: 5.917

4.  Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.

Authors:  Daisuke Ono; Yukiko Shishido-Hara; Saneyuki Mizutani; Yoko Mori; Keiko Ichinose; Mutsufusa Watanabe; Tohru Tanizawa; Takanori Yokota; Toshiki Uchihara; Hiroto Fujigasaki
Journal:  Neuropathology       Date:  2019-06-02       Impact factor: 1.906

5.  Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis.

Authors:  Ryusei Nishigori; Yoko Warabi; Yukiko Shishido-Hara; Kazuo Nakamichi; Yasuhiro Nakata; Takashi Komori; Eiji Isozaki
Journal:  Intern Med       Date:  2019-07-31       Impact factor: 1.271

6.  In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.

Authors:  Douglas G Widman; Savanna Gornisiewicz; Sharon Shacham; Sharon Tamir
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.